🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to determine whether the initiation of a vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03-30
Trial ID
NCT01528254
Treatments Being Tested
Phase IIIb, randomized, multicenter, double-blind, prospective study to eva...
Status
Completed
Location
Centro de Investigación y Avances Médicos Especializados
Start Date
2023-03-21
Trial ID
NCT04841096
The present study is a phase I, single-centre, double-blind, randomized, cr...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2011-11
Trial ID
NCT02749032
Treatments Being Tested
Men and post- or induced menopausal women with ER\[+\] and/or PgR\[+\], HER...
Status
Completed
Location
Hospital General Universitario de Alicante
Start Date
2020-10-23
Trial ID
NCT04300790
Treatments Being Tested
This study investigates the effect of vildagliptin, an inhibitor of the enz...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT03819127
Treatments Being Tested
The purpose of this study is to compare the effect of a single administrati...
Status
Completed
Location
UH Toulouse
Start Date
2010-10
Trial ID
NCT01452113
Treatments Being Tested
The aim of this study is to evaluate the effect of adding Vildagliptin vers...
Status
Completed
Location
Faculty of Pharmacy - Damanhour University.
Start Date
2018-10-08
Trial ID
NCT03693560
Treatments Being Tested
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects appr...
Status
Recruiting
Location
October 6 university hospital
Start Date
2023-11-25
Trial ID
NCT06142656
Treatments Being Tested
The aim of this study is to evaluate the effect of vildagliptin on copeptin...
Status
Completed
Location
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes.
Start Date
2022-10-01
Trial ID
NCT06068686
Treatments Being Tested
Dipeptidyl peptidase-4 (DPP-4) inactivates glucagon-like peptide-1 (GLP-1)....
Status
Completed
Location
Multiple Locations
Start Date
2016-03-01
Trial ID
NCT03500900
Treatments Being Tested